Literature DB >> 23788304

Predictors of atrial fibrillation recurrence after atrial fibrillation ablation with cryoballoon.

Banu Evranos1, Kudret Aytemir, Ali Oto, Sercan Okutucu, Uğur Karakulak, Levent Şahiner, Barış Kaya, Giray Kabakçı.   

Abstract

BACKGROUND: Catheter ablation of atrial fibrillation is recommended for patients with symptomatic paroxysmal atrial fibrillation (PAF) despite anti-arrhythmic drugs (AADs). Radiofrequency ablation is widely accepted as an effective treatment for PAF. Cryoenergy by cryoballoon technique is an alternative to radiofrequency (RF) ablation. Cryoballoon ablation is safe, and has a similar success rate in comparison to RF ablation. AF recurrence with cryoballoon ablation is roughly 30%. The aim of this study is to determine the predictors of AF recurrence after cryoballoon ablation. METHODS AND
RESULTS: Sixty one patients with symptomatic PAF despite AADs without structural heart disease were included. Cryoballoon ablation was performed in 60 patients (36 males, mean age: 54.6 ± 10.7, mean left atrium size: 3.74 ± 0.39 mm). Transthoracic echocardiography including tissue Doppler imaging was performed in all subjects during sinus rhythm at baseline and after the ablation. Intra-atrial and inter-atrial electromechanical delays, and PA-lateral were measured. All patients were scheduled for 24 h Holter recording at baseline and at 3, 6, 9 months follow-up. Venous samples were collected to measure CK-MB, Troponin-T (TnT), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels at baseline and 24 h after ablation. Median follow up was 10 (8-12) months. Forty eight (80%) patients were in sinus rhythm during the follow up. In receiver operating curve (ROC) analysis, intraleft atrial electromechanical delay and PA-lateral achieve an area under the curve (AUC) 0.97 (p < 0.001) and 0.69 (p < 0.001) for the ability to predict AF recurrence. A cut-off value for baseline intra left atrial electromechanical delay of 29.5 ms predicted AF recurrence with sensitivity of 85% and specifity of 98%. A cut-off value for PA-lateral of 125 ms predicted AF recurrence with sensitivity of 80% and specifity of 90%. In ROC analysis, age achieves an AUC 0.822 (p = 0.006) for the ability to predict AF recurrence. A cut-off value for age of 64 predicted AF recurrence with sensitivity of 71% and specifity of 90%. Early recurrence of AF (HR = 60, 95% CI 18.61-417.86, p < 0.001) predicted also late recurrence of AF.
CONCLUSIONS: The increase in AF recurrence by increased intraleft atrial electromechanical delay, PA-lateral and older age show the importance of substrate in AF mechanism. Early recurrence was the strongest predictor of late recurrence of AF; therefore, existence of blanking period for cryoballoon ablation should be questioned.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23788304     DOI: 10.5603/CJ.2013.0075

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  12 in total

1.  Echocardiographic predictors of atrial fibrillation recurrence after catheter ablation: A literature review.

Authors:  Aleksandra Liżewska-Springer; Alicja Dąbrowska-Kugacka; Ewa Lewicka; Łukasz Drelich; Tomasz Królak; Grzegorz Raczak
Journal:  Cardiol J       Date:  2018-06-20       Impact factor: 2.737

2.  Predictors of arrhythmia recurrence after balloon cryoablation of atrial fibrillation: the value of CAAP-AF risk scoring system.

Authors:  Mohamed Sanhoury; Massimo Moltrasio; Fabrizio Tundo; Stefania Riva; Antonio Dello Russo; Michela Casella; Claudio Tondo; Gaetano Fassini
Journal:  J Interv Card Electrophysiol       Date:  2017-04-18       Impact factor: 1.900

3.  Left Atrial Dyssynchrony in Dilated Cardiomyopathy: Diastolic Dysfunction Matters but Left Bundle Branch Block Does Not.

Authors:  Chinami Miyazaki
Journal:  Int J Heart Fail       Date:  2019-10-29

4.  Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation.

Authors:  Demet Menekşe Gerede; Başar Candemir; Veysel Kutay Vurgun; Siamak Mousavi Aghdam; Aynur Acıbuca; Özgür Ulaş Özcan; Hüseyin Göksülük; Celal Kervancıoğlu; Çetin Erol
Journal:  Anatol J Cardiol       Date:  2015-09-15       Impact factor: 1.596

5.  Left atrial dyssynchrony time measured by tissue Doppler imaging to predict atrial fibrillation recurrences after pulmonary vein isolation: is this a mirage or the panacea?

Authors:  Narendra Kumar; Pietro Bonizzi; Masih Mafi Rad; Theo Lankveld
Journal:  Anatol J Cardiol       Date:  2015-01-21       Impact factor: 1.596

6.  Left atrial dyssynchrony time measured by tissue Doppler imaging to predict atrial fibrillation recurrences after pulmonary vein isolation.

Authors:  Ahmed Salah; Hui Yang; Liang Tang; Xuping Li; Qiming Liu; Shenghua Zhou
Journal:  Anatol J Cardiol       Date:  2014-06-03       Impact factor: 1.596

7.  Assessment of Subclinical Cardiac Alterations and Atrial Electromechanical Delay by Tissue Doppler Echocardiography in Patients with Nonfunctioning Adrenal Incidentaloma.

Authors:  Gulizar Sokmen; Murat Sahin; Dilek Tuzun; Abdullah Sokmen; Hanife Bolat; Ayten Oguz; Adem Doganer; Huseyin Nacar; Kamile Gul
Journal:  Arq Bras Cardiol       Date:  2018-10-11       Impact factor: 2.000

Review 8.  Clinical scores for outcomes of rhythm control or arrhythmia progression in patients with atrial fibrillation: a systematic review.

Authors:  Hai Deng; Ying Bai; Alena Shantsila; Laurent Fauchier; Tatjana S Potpara; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2017-05-30       Impact factor: 5.460

9.  Evaluation of the association between stroke/transient ischemic attack and atrial electromechanical delay in patients with paroxysmal atrial fibrillation.

Authors:  Nermin Bayar; Çağın Mustafa Üreyen; Zehra Erkal; Selçuk Küçükseymen; Serkan Çay; Göksel Çağırcı; Şakir Arslan
Journal:  Anatol J Cardiol       Date:  2015-11-25       Impact factor: 1.596

10.  Prediction of recurrence after cryoballoon ablation therapy in patients with paroxysmal atrial fibrillation.

Authors:  Ewa Lewicka
Journal:  Anatol J Cardiol       Date:  2016-07       Impact factor: 1.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.